Profil

Fransolet Maïté

See author's contact details
Main Referenced Co-authors
Nisolle, Michelle  (45)
Munaut, Carine  (44)
Labied, Soraya  (40)
Henry, Laurie  (39)
Noël, Agnès  (37)
Main Referenced Keywords
Fertility preservation (4); Granulosa cells (3); Z-VAD-FMK (3); apoptosis (2); fertility preservation (2);
Main Referenced Unit & Research Centers
Laboratoire de Biologie des Tumeurs et du Développement (1)
Main Referenced Disciplines
Reproductive medicine (gynecology, andrology, obstetrics) (49)
Biochemistry, biophysics & molecular biology (1)

Publications (total 50)

The most downloaded
209 downloads
Fransolet, M., Labied, S., Henry, L., Masereel, M.-C., Rozet, E., Kirschvink, N., Nisolle, M., & Munaut, C. (2014). Strategies for Using the Sheep Ovarian Cortex as a Model in Reproductive Medicine. PLoS ONE, 9 (3), 91073. doi:10.1371/journal.pone.0091073 https://hdl.handle.net/2268/165464

The most cited

69 citations (Scopus®)

Foster, B., Balassa, T., Benen, T., Dominovic, M., Elmajian, G., Florova, V., Fransolet, M., Kestlerova, A., Kmiecik, G., Kostadinova, I., Kyvelidou, C., Meggyes, M., Mincheva, M., Moro, L., Pastuschek, J., Spoldi, V., Wandernoth, P., Weber, M., Toth, B., & Markert, U. (2016). Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproduction. Critical Reviews in Clinical Laboratory Sciences. doi:10.1080/10408363.2016.1190682 https://hdl.handle.net/2268/197680

NOEL, L., Fransolet, M., Jacobs, N., Foidart, J.-M., Nisolle, M., & Munaut, C. (2020). A paracrine interaction between granulosa cells and leukocytes in the preovulatory follicle causes the increase in follicular G-CSF levels. Journal of Assisted Reproduction and Genetics, 37, 405-416. doi:10.1007/s10815-020-01692-y
Peer reviewed

Terren, C., Fransolet, M., Ancion, M., Nisolle, M., & Munaut, C. (23 December 2019). Slow Freezing Versus Vitrification of Mouse Ovaries: from Ex Vivo Analyses to Successful Pregnancies after Auto-Transplantation. Scientific Reports, 9 (1), 19668. doi:10.1038/s41598-019-56182-8
Peer Reviewed verified by ORBi

Terren, C., Fransolet, M., NISOLLE, M., & Munaut, C. (2019). Comparison between two ovarian tissue cryopreservation techniques (slow-freezing versus vitrification) [Poster presentation]. BACR-Annual Meeting.

Terren, C., Fransolet, M., NISOLLE, M., & Munaut, C. (2019). Is slow-freezing still better than vitrification for ovarian tissue cryopreservation? [Poster presentation]. Séminaire des chercheurs Télévie 2019.

Fransolet, M., NOEL, L., HENRY, L., LABIED, S., Blacher, S., NISOLLE, M., & Munaut, C. (2019). Evaluation of Z-VAD-FMK as an anti-apoptotic drug to prevent granulosa cell apoptosis and follicular death after human ovarian tissue transplantation. Journal of Assisted Reproduction and Genetics. doi:10.1007/s10815-018-1353-8
Peer Reviewed verified by ORBi

Terren, C., Fransolet, M., NISOLLE, M., & Munaut, C. (2018). Slow-freezing versus vitrification of mouse ovary: from ex vivo analyses to pregnancy after autotransplantation [Poster presentation]. Joint Meeting GIGA-Cancer Day 2018.

Fransolet, M. (2016). Contribution to the study of restoring female fertility using a xenograft model of cropreserved ovarian tissue [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315250

Munaut, C., Fransolet, M., LABIED, S., & NISOLLE, M. (03 June 2016). Development and assessment of a new closed system for ovarian tissue vitrification [Paper presentation]. 12ième journées scientifiques du GRECOT, Paris, France.

Fransolet, M. (02 June 2016). Préservation de la fertilité féminine : Etude de l’effet de l’anti-apoptotique Z-VAD-FMK sur l’apoptose des cellules de la granulosa et la perte folliculaire après transplantation de tissu ovarien cryopréservé [Paper presentation]. 12ième journées scientifiques du Groupe de Recherche et d’Etude sur la Cryoconservation de l’Ovaire et du Testicule.

Foster, B., Balassa, T., Benen, T., Dominovic, M., Elmajian, G., Florova, V., Fransolet, M., Kestlerova, A., Kmiecik, G., Kostadinova, I., Kyvelidou, C., Meggyes, M., Mincheva, M., Moro, L., Pastuschek, J., Spoldi, V., Wandernoth, P., Weber, M., Toth, B., & Markert, U. (2016). Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproduction. Critical Reviews in Clinical Laboratory Sciences. doi:10.1080/10408363.2016.1190682
Peer Reviewed verified by ORBi

Fransolet, M., NOEL, L., HENRY, L., LABIED, S., Noël, A., Nisolle, M., & Munaut, C. (25 January 2016). − Evaluation of Z-VAD-FMK as an anti-apoptotic drug to prevent granulosa cells apoptosis and follicle death after ovarian tissue transplantation [Poster presentation]. GIGA day.

HENRY, L., Fransolet, M., LABIED, S., Blacher, S., MASEREEL, M.-C., Foidart, J.-M., Noël, A., Nisolle, M., & Munaut, C. (2016). Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival. Journal of Ovarian Research. doi:10.1186/s13048-016-0216-0
Peer Reviewed verified by ORBi

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., NISOLLE, M., & Munaut, C. (14 June 2015). In vitro evaluation of an anti-apoptotic drug, Z-VAD-FMK, for further use in ovarian tissue transplantation [Poster presentation]. The 31th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbonne, Portugal.

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (13 May 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. GIGA-Cancer day.

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (11 February 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. Séminaire des jeunes chercheurs Télévie.

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (31 January 2015). Follicular maintenance after oavrian tissue transplantation with the anti-apoptotic drug Z-VAD-FMK [Poster presentation]. Meeting annuel de la Belgian Association for Cancer Research (BACR).

HENRY, L., Fransolet, M., LABIED, S., Masereel, M.-C., Blacher, S., Donneau, A.-F., Kirschvink, N., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (27 January 2015). Limitation of damage to ovarian cortex during cryopreservation by addition of anti-apoptotic drugs in transport and freezing media [Poster presentation]. GIGA day.

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (27 January 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. GIGA day.

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut. (16 January 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. International Society of Fertility Preservation (ISFP) meeting: “Freezing of oocytes, embryos and ovarian tissue: focus on fertility management and fertility preservation”.

Henry, L., LABIED, S., Fransolet, M., Kirschvink, N., Blacher, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (2015). Isoform 165 of vascular endothelial growth factor in collagen matrix improves ovine cryopreserved ovarian tissue revascularisation after xenotransplantation in mice. Reproductive Biology and Endocrinology, 13 (1), 15. doi:10.1186/s12958-015-0015-2
Peer Reviewed verified by ORBi

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Nisolle, M., & Munaut, C. (2015). In vitro evaluation of the anti-apoptotic drug Z-VAD-FMK on human ovarian granulosa cell lines for further use in ovarian tissue transplantation. Journal of Assisted Reproduction and Genetics. doi:10.1007/s10815-015-0536-9
Peer Reviewed verified by ORBi

Fransolet, M., Henry, L., LABIED, S., Masereel, M.-C., Blacher, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (2015). Influence of mouse strain on ovarian tissue recovery after engraftment with angiogenic factor. Journal of Ovarian Research, 8 (1), 14. doi:10.1186/s13048-015-0142-6
Peer Reviewed verified by ORBi

Fransolet, M. (19 December 2014). Female fertility preservation: Evaluation of pro‐angiogenic and anti‐apoptotic drugs for further use in ovarian tissue transplantation [Paper presentation]. GIGA‐Cancer seminar.

HENRY, L., Fransolet, M., LABIED, S., MASEREEL, M.-C., Blacher, S., Donneau, A.-F., Kirschvink, N., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (14 November 2014). Use of anti-apoptotic drugs in transport and freezing media of cryopreserved sheep ovarian cortex to improve tissue survival [Poster presentation]. 32ème meeting scientifique de la Belgian Society of Reproductive Medicine (BSRM).

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (14 November 2014). Potential effect of the anti-apoptotic drug Z-VAD-FMK on follicular maintenance in ovarian tissue cryopreservation [Poster presentation]. 32ème meeting scientifique de la Belgian Society of Reproductive Medicine (BSRM).

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (30 September 2014). Does Z-VAD-FMK treatment could decrease follicular loss after autografting of cryopreserved ovarian tissue? [Poster presentation]. Mini-symposium annuel de l’EDT-Cancérologie Expérimentale.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (19 May 2014). Ovarian tissue recovery in SCID and NOD-SCID mice after VEGF111 or VEGF165 graft treatment [Poster presentation]. GIGA-Cancer day.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (15 May 2014). Impact of mice strains in ovarian tissue recovery after VEGF111 or VEGF165 graft treatment [Poster presentation]. BioLiège Bioforum 2014.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (01 February 2014). Impact of mice strains in ovarian tissue recovery after VEGF111 or VEGF165 graft treatment [Poster presentation]. Belgian Association for Cancer Research (BACR) annual meeting 2014.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (27 January 2014). Impact of mice strains in ovarian tissue recovery after VEGF111 or VEGF165 graft treatment [Poster presentation]. GIGA day.

Fransolet, M., Labied, S., Henry, L., Masereel, M.-C., Rozet, E., Kirschvink, N., Nisolle, M., & Munaut, C. (2014). Strategies for Using the Sheep Ovarian Cortex as a Model in Reproductive Medicine. PLoS ONE, 9 (3), 91073. doi:10.1371/journal.pone.0091073
Peer Reviewed verified by ORBi

Fransolet, M., HENRY, L., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (05 December 2013). Z-VAD-FMK treatment prevents granulosa cells apoptosis induced by etoposide but not by hypoxia and serum starvation in vitro [Poster presentation]. Séminaire des chercheurs Télévie 2014.

Fransolet, M., HENRY, L., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (07 November 2013). Z-VAD-FMK treatment prevents granulosa cells apoptosis induced by etoposide but not by hypoxia and serum starvation in vitro [Poster presentation]. 3rd World Congress of the International Society for Fertility Preservation (ISFP).

Fransolet, M. (18 September 2013). Do anti-apoptotic drugs could improve tissue viability after ovarian cortical fragments transplantation? [Paper presentation]. 10ème congrès de l’European Society of Gynecology.

HENRY, L., Fransolet, M., LABIED, S., Munaut, C., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (17 May 2013). Effect of anti-apoptotic drugs to prevent follicles loss during ovarian cortex transport and cryopreservation [Poster presentation]. GIGA-Cancer day.

Fransolet, M., HENRY, L., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (17 May 2013). Do anti-apoptotic drugs prevent follicle loss after ovarian cortical graft to patient in remission? [Poster presentation]. GIGA-Cancer day.

HENRY, L., Fransolet, M., LABIED, S., Munaut, C., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (21 March 2013). Do anti-apoptotic drugs prevent follicles loss during ovarian cortex transport and cryopreservation? [Poster presentation]. The International Congress on Oncological Perspectives of Fertility Preservation: Gynecological & Breast Cancer.

Fransolet, M., HENRY, L., Rozet, E., Blacher, S., Masereel, M.-C., Kirschvink, N., Foidart, J.-M., Noël, A., Nisolle, M., LABIED, S., & Munaut, C. (02 February 2013). How to use sheep ovarian tissue as a model to restore fertility in young women who received gonadotoxic treatment? [Poster presentation]. Belgian Association for Cancer Research (BACR) annual meeting.

Labied, S., Delforge, Y., Munaut, C., Blacher, S., Colige, A., Delcombel, R., HENRY, L., Fransolet, M., JOUAN, C., Perrier d'Hauterive, S., Noël, A., Nisolle, M.* , & Foidart, J.-M.*. (2013). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Transplantation, 95 (3), 426-433. doi:10.1097/TP.0b013e318279965c
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Fransolet, M., HENRY, L., Rozet, E., Blacher, S., Masereel, M.-C., Kirschvink, N., Noël, A., Foidart, J.-M., NISOLLE, M., Labied, S., & Munaut, C. (10 December 2012). Use of Sheep Ovarian Tissue as a Model to Restore Fertility in Young Cancerous Women [Poster presentation]. Séminaire des chercheurs Télévie 2013.

HENRY, L., Delforge, Y., Blacher, S., Colige, A., Delcombel, R., Fransolet, M., JOUAN, C., PERRIER d'HAUTERIVE, S., Noël, A., Nisolle, M., Foidart, J.-M., Munaut, C., & LABIED, S. (10 December 2012). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation [Poster presentation]. Televie's Researchers Seminar.

HENRY, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (30 November 2012). Does vascular endothelial growth factor improve ovarian tissue recovery after cryopreservation? [Poster presentation]. Belgian Society of Reproductive Medicine.

Fransolet, M., HENRY, L., Rozet, E., Blacher, S., Masereel, M.-C., Kirschvink, N., Foidart, J.-M., Noël, A., Nisolle, M., Munaut, C., & LABIED, S. (30 November 2012). Assessment of follicular density in sheep ovarian tissue and impact on experimental results [Poster presentation]. Belgian Society of Reproductive Medicine.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., PERRIER d'HAUTERIVE, S., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (22 June 2012). Influence of VEGF111 treatment on ovarian tissue xenografts in different mice strains [Poster presentation]. GIGA-Cancer day.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., PERRIER d'HAUTERIVE, S., Foidart, J.-M., Noël, A., Nisolle, M., Munaut, C., & LABIED, S. (04 May 2012). Comparison of different mice strains to test ovarian VEGF111 treated graft recovery [Poster presentation]. GIGA day.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., PERRIER d'HAUTERIVE, S., Foidart, J.-M., Noël, A., Munaut, C., LABIED, S., & Nisolle, M. (18 April 2012). Impact of mice strains in ovarian tissue recovery after VEGF111 graft treatment [Poster presentation]. Biomedica, The European Life Sciences Summit.

Henry, L., Fransolet, M., Labied, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (2012). Does vascular endothelial growth factor improve ovarian tissue recovery after cryopreservation? In Giornale italiano di obstetricia e gynecologia (pp. 34(1):203).
Peer reviewed

HENRY, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Kirschvinck, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Does isoforms 111 and 165 of vascular endothelial growth factor (VEGF111 and 165) improve transplanted ovarian tissue survival? Journal of Assisted Reproduction and Genetics, 28, 1009-1010.

LABIED, S., Delforge, Y., Blacher, S., Munaut, C., Signole, N., Colige, A., Janssen, L., HENRY, L., Fransolet, M., PERRIER d'HAUTERIVE, S., JOUAN, C., Kirschvink, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Journal of Assisted Reproduction and Genetics, 28, 1099.

Henry, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Does isoforms 111 and 165 of vascular endothelial growth factor (VEGF111 and 165) improve transplanted ovarian tissue survival? Journal of Assisted Reproduction and Genetics, 28, 1009-10.
Peer Reviewed verified by ORBi

Contact ORBi